Literature DB >> 1989598

Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood.

L E DeForge1, D G Remick.   

Abstract

While the production of tumor necrosis factor (TNF) and interleukin-6 (IL-6) in septic shock and other inflammatory states is well established, the role of interleukin-8 (IL-8), a recently described neutrophil chemoattractant and activator, has yet to be fully elucidated. Using lipopolysaccharide (LPS)-stimulated human whole blood as an ex vivo model of sepsis, the kinetics of messenger RNA (mRNA) up-regulation and protein release of these cytokines were examined. Two waves of cytokine gene activation were documented. TNF and IL-6 were induced in the first wave with mRNA levels peaking between 2-4 hours and then rapidly declining. TNF and IL-6 protein peaked at 4-6 hours and then stabilized. IL-8 mRNA and protein were induced in the first wave, reached a plateau between 6-12 hours, and rose again in a second wave which continued to escalate until the end of the 24 hour study. These data demonstrate the complex patterns of cytokine gene expression and suggest that production of early mediators may augment continued expression of IL-8 to recruit and retain neutrophils at a site of inflammation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989598     DOI: 10.1016/0006-291x(91)90478-p

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  72 in total

1.  Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.

Authors:  L F Lee; J S Haskill; N Mukaida; K Matsushima; J P Ting
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway.

Authors:  Ryan P Nolan; Andrea G Bree; Anup Zutshi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-09-26       Impact factor: 2.745

3.  The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6.

Authors:  Shi Jiao; Zhen Zhang; Chuanchuan Li; Min Huang; Zhubing Shi; Yanyan Wang; Xiaomin Song; Heng Liu; Chunyang Li; Min Chen; Wenjia Wang; Yun Zhao; Zhengfan Jiang; Hongyan Wang; Catherine C L Wong; Chen Wang; Zhaocai Zhou
Journal:  Nat Immunol       Date:  2015-02-02       Impact factor: 25.606

4.  Transcriptional and post-transcriptional regulation of interleukin-8.

Authors:  L H Villarete; D G Remick
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

5.  Protein signaling networks from single cell fluctuations and information theory profiling.

Authors:  Young Shik Shin; F Remacle; Rong Fan; Kiwook Hwang; Wei Wei; Habib Ahmad; R D Levine; James R Heath
Journal:  Biophys J       Date:  2011-05-18       Impact factor: 4.033

6.  Differential regulation of IL-8 by IL-1beta and TNFalpha in hyaline membrane disease.

Authors:  K Y Kwong; C A Jones; R Cayabyab; C Lecart; C L Stotts; I Randhawa; R Ramanathan; N Khuu; P Minoo; R A deLemos
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

7.  The biphasic mRNA expression pattern of bovine interleukin-8 in Pasteurella haemolytica lipopolysaccharide-stimulated alveolar macrophages is primarily due to tumor necrosis factor alpha.

Authors:  R L Lafleur; M S Abrahamsen; S K Maheswaran
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes.

Authors:  S Shalekoff; L Page-Shipp; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Inhibition of endotoxin-induced interleukin 8 release by teicoplanin in human whole blood.

Authors:  A Focà; G Matera; M C Berlinghieri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

10.  Detection of gene expression in an individual cell type within a cell mixture using microarray analysis.

Authors:  Penelope A Bryant; Gordon K Smyth; Roy Robins-Browne; Nigel Curtis
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.